Finished
Clinical Investigation to Validate the Safety and Performance of the ABLE Exoskeleton Device for Individuals With Multiple Sclerosis in a Clinical Setting
NCT06261541 · ABLE Human Motion S.L. · Updated 31 July 2024
- What is being tested
- ABLE Exoskeleton
- For
- Multiple Sclerosis
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 70 years. About 33 people. The full rules are on the registry page.
- Where
- Spain
- When
- Starts or started 8 April 2024, ends 30 July 2024. Registered 15 Feb 2024.
- Results
- None posted yet.
In the researchers' words
The primary objective of the study is to validate the safety and performance of the ABLE Exoskeleton device in people with multiple sclerosis during a 10-session gait training program in a clinical setting. Furthermore, the potential effects of the training on walking, and balance function, general health status, user satisfaction, and quality of life will be assessed.
Sites
- Fundación Esclerosis Múltiple Madrid (FEMM)Madrid, Spain